Chronic constipation
Conditions
Interventions
Experimental group:Cinitapride Hydrogen Tartrate + PEG
Sponsors
Handan Frist Hospital
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 20 years. 2.Meet the diagnostic criteria for chronic constipation. 3.Planned to perform painless electronic colonoscopy. 4.Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with a known allergy to the drug components used in this study; 2.Patients with a history of gastrointestinal surgery, inflammatory bowel disease, gastrointestinal bleeding, obstruction, or perforation; 3.Patients who have been diagnosed with tardive dyskinesia due to antipsychotic treatment; 4.Patients with hereditary galactose intolerance, Lapp lactase deficiency, or glucose/galactose absorption disorder; 5.Patients with a history of severe liver or kidney insufficiency, congestive heart failure, respiratory failure, severe coagulation disorders, stroke, myocardial infarction, spinal cord injury, Parkinson’s disease, psychiatric disorders, etc.; 6.Patients who have used other prokinetic drugs within one week before colonoscopy; 7.Patients currently taking tricyclic antidepressants or opioid drugs; 8.Pregnant or breastfeeding women; 9.Patients whom the investigators consider unsuitable for participation in this study for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston Bowel Preparation Scale Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of Boston Bowel Preparation Scale Score <6 points.;Boston scores of each bowel segment.;Intraluminal bubble score in the bowel;Incidence rate of adverse events.;Polyp Detection Rate; | — |
Countries
China
Contacts
Public ContactLu Xinqing
Handan Frist Hospital
Outcome results
None listed